Kimia Biosciences Limited (BOM:530313)

India · Delayed Price · Currency is INR

31.00

-1.00 (-3.13%)

At close: Oct 1, 2026

Market Cap	1.47B -13.9%
Revenue (ttm)	1.12B -6.7%
Net Income	71.86M -18.2%
EPS	1.60 -14.2%
Shares Out	47.31M
PE Ratio	19.34
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,073
Open	32.50
Previous Close	32.00
Day's Range	29.51 - 32.50
52-Week Range	23.20 - 43.28
Beta	1.16
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Kimia Biosciences

Kimia Biosciences Limited engages in the manufacturing and sale of pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients (APIs) in various therapeutic categories, including gastrointestinal agent, anti-coagulant, anti-hypertensive, vitamin B1, anti-histamine, anti-convulsant, central stimulant, anti-diabetic, anti-fungal, overactive bladder, anti-inflammatory, prokinetic agent, and hepatoprotective agent, as well as lipid lowering agent, thiamine supplement, anti-acne, NSAID, cholerectic agen... [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 1993

Employees 205

Stock Exchange Bombay Stock Exchange

Ticker Symbol 530313

Full Company Profile

Financial Performance

In fiscal year 2026, Kimia Biosciences's revenue was 1.15 billion, a decrease of -3.39% compared to the previous year's 1.19 billion. Earnings were 74.34 million, a decrease of -22.67%.

Financial Statements